Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder

  • Zillich, Eric|||0000-0003-3704-7243
  • Belschner, Hanna
  • Avetyan, Diana
  • Andrade-Brito, Diego
  • Martínez-Magaña, José Jaime
  • Frank, Josef|||0000-0003-4867-9465
  • Mechawar, Naguib|||0000-0003-4960-756X
  • Turecki, Gustavo|||0000-0003-4075-2736
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Fernàndez-Castillo, Noèlia|||0000-0001-9948-0312
  • Cormand, Bru|||0000-0001-5318-4382
  • Montalvo-Ortiz, Janitza L.|||0000-0002-7657-8365
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Hansson, Anita C.|||0000-0003-1821-3920
  • Rietschel, Marcella|||0000-0002-5236-6149
  • Spanagel, Rainer|||0000-0003-2151-4521
  • Witt, Stephanie H.|||0000-0002-1571-1468
  • Zillich, Lea|||0000-0001-7457-374X
Structural and functional changes of the brain are assumed to contribute to excessive cocaine intake, craving, and relapse in cocaine use disorder (CUD). Epigenetic and transcriptional changes were hypothesized as a molecular basis for CUD-associated brain alterations. Here we performed a multi-omics study of CUD by integrating epigenome-wide methylomic (N = 42) and transcriptomic (N = 25) data from the same individuals using postmortem brain tissue of Brodmann Area 9 (BA9). Of the N = 1 057 differentially expressed genes (p < 0.05), one gene, ZFAND2A, was significantly upregulated in CUD at transcriptome-wide significance (q < 0.05). Differential alternative splicing (AS) analysis revealed N = 98 alternatively spliced transcripts enriched in axon and dendrite extension pathways. Strong convergent overlap in CUD-associated expression deregulation was found between our BA9 cohort and independent replication datasets. Epigenomic, transcriptomic, and AS changes in BA9 converged at two genes, ZBTB4 and INPP5E. In pathway analyses, synaptic signaling, neuron morphogenesis, and fatty acid metabolism emerged as the most prominently deregulated biological processes. Drug repositioning analysis revealed glucocorticoid receptor targeting drugs as most potent in reversing the CUD expression profile. Our study highlights the value of multi-omics approaches for an in-depth molecular characterization and provides insights into the relationship between CUD-associated epigenomic and transcriptomic signatures in the human prefrontal cortex.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Primary Ciliary Dyskinesia and Retinitis Pigmentosa, Novel RPGR Variant and Possible Modifier Gene

  • Baz-Redón, Noelia|||0000-0003-1704-3413
  • Sánchez-Bellver, Laura|||0000-0003-3534-704X
  • Fernández Cancio, Mónica|||0000-0003-1872-3488
  • Rovira-Amigo, Sandra|||0000-0001-9896-0621
  • Burgoyne, Thomas|||0000-0002-8428-720X
  • Ranjit, Rai
  • Aquino, Virginia|||0000-0002-2329-8159
  • Toro-Barrios, Noemí
  • Carmona, Rosario|||0000-0003-2563-9591
  • Polverino, Eva|||0000-0002-4058-5109
  • Cols, Maria|||0000-0002-1060-3337
  • Moreno Galdó, Antonio|||0000-0002-2496-9786
  • Camats Tarruella, Núria|||0000-0002-4863-8201
  • Marfany, Gemma|||0000-0001-7941-983X
We report a novel RPGR missense variant co-segregated with a familial X-linked retinitis pigmentosa (XLRP) case. The brothers were hemizygous for this variant, but only the proband presented with primary ciliary dyskinesia (PCD). Thus, we aimed to elucidate the role of the RPGR variant and other modifier genes in the phenotypic variability observed in the family and its impact on motile cilia. The pathogenicity of the variant on the RPGR protein was evaluated by in vitro studies transiently transfecting the mutated RPGR gene, and immunofluorescence analysis on nasal brushing samples. Whole-exome sequencing was conducted to identify potential modifier variants. In vitro studies showed that the mutated RPGR protein could not localise to the cilium and impaired cilium formation. Accordingly, RPGR was abnormally distributed in the siblings' nasal brushing samples. In addition, a missense variant in CEP290 was identified. The concurrent RPGR variant influenced ciliary mislocalisation of the protein. We provide a comprehensive characterisation of motile cilia in this XLRP family, with only the proband presenting PCD symptoms. The variant's pathogenicity was confirmed, although it alone does not explain the respiratory symptoms. Finally, the CEP290 gene may be a potential modifier for respiratory symptoms in patients with RPGR mutations.